Acetazolamide
- Product NDC
- 70771-1490
- 11-digit product format
- 707711490
- Labeler code
- 70771
- Product ID
- 70771-1490_7cb9ae99-0542-483d-b7b2-8eef7154bcd5
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetazolamide
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Zydus Lifesciences Limited
- Application
- ANDA206533
- Marketing category
- ANDA
- Marketing start
- 2020-01-09
- Marketing end
- 0000-00-00
- Substance
- ACETAZOLAMIDE SODIUM
- Active strength
- 500 mg/5mL
- Pharmacologic classes
- Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA], Sulfonamides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70771-1490 | ACETAZOLAMIDE INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION [ZYDUS LIFESCIENCES LIMITED] | 3 | Legacy NDC | 20221019_1269804e-7d32-466c-83e7-99e6ddceb8b2.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70771-1490-1 | 70771149001 | 1 VIAL in 1 CARTON (70771-1490-1) > 5 mL in 1 VIAL | 1 vial | 2020-01-09 | 0000-00-00 | No | No | Current |